Breaking News Instant updates and real-time market news.

CASI

Casi Pharmaceuticals

$1.52 /

-0.01 (-0.65%)

07:09
09/29/20
09/29
07:09
09/29/20
07:09

Casi Pharmaceuticals restructures partnership with Juventas Cell Therapy

CASI Pharmaceuticals announced a restructuring of its partnership with Juventas Cell Therapy Ltd. relating to CNCT19, an investigational CD19 CAR-T Cell therapy. Juventas is currently developing CNCT19 for the treatment of patients with relapsed B-cell Non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia, and expects to initiate registration trials in early 2021. Under the terms of the original licensing agreement between CASI and Juventas, CASI obtained a worldwide license for the commercialization of CNCT19 and Juventas was responsible for the clinical development, manufacturing and supply of CNCT19. As part of the original agreement, CASI Biopharmaceuticals invested in Juventas' Series A financing. The original agreement also provided that CASI would be responsible for payment of certain sales royalties and a development milestone in the amount of RMB 70M upon the initiation of the registration trials. Effective as of September 22, Juventas and its shareholders agreed to certain terms and conditions in connection with Juventas' Series B financing. In order to facilitate the Series B financing, CASI agreed to restructure its partnership with Juventas by amending and supplementing its original licensing agreement. Under the Supplementary Agreement, CASI and Juventas will partner to co-commercialize CNCT19 and jointly be responsible for forming an integrated marketing team to carry out marketing activities, and CASI will continue to be responsible for recruiting and establishing a sales team to commercialize CNCT19. In addition, the Supplementary Agreement provides CASI with co-commercial rights to a second pipeline product from Juventas, subject to certain terms and conditions. As part of this transaction, Juventas will waive the RMB 70M milestone payment due from CASI in connection with the upcoming start of registration trials for CNCT19. CASI and Juventas will share a percentage of total net profits, with CASI receiving a tiered percentage of up to 50% of the net profit from commercial sales of CNCT19 depending on annual net sales, with a specified minimum annual target net profit to be distributed to Juventas as a percentage of net profit from commercial sales. In addition, CASI will be responsible for single digit royalty fee equal to a percentage of net sales that varies by region. As part of this transaction, CASI Wuxi Bio will invest RMB 70M in Juventas' Series A Plus equity, resulting in equity ownership of approximately 19.65% and entitling it to appoint a director to the Juventas' board of directors.

  • 22

    Jul

CASI Casi Pharmaceuticals
$1.52 /

-0.01 (-0.65%)

03/24/20 H.C. Wainwright
Casi Pharmaceuticals price target lowered to $3.50 from $7 at H.C. Wainwright

TODAY'S FREE FLY STORIES

Hot Stocks
Vifor Pharma, Cara Therapeutics enter license agreement for Korsuva Injection » 05:24
10/20/20
10/20
05:24
10/20/20
05:24
GNHAF

Vifor Pharma

$0.00 /

+ (+0.00%)

, CARA

Cara Therapeutics

$13.94 /

-0.07 (-0.50%)

Vifor Pharma (GNHAF) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CARA Cara Therapeutics
$13.94 /

-0.07 (-0.50%)

GNHAF Vifor Pharma
$0.00 /

+ (+0.00%)

09/04/20 Stifel
Vifor Pharma price target lowered to CHF 158 from CHF 160 at Stifel
09/02/20 Barclays
Vifor Pharma price target lowered to CHF 140 from CHF 155 at Barclays
08/26/20 Deutsche Bank
Vifor Pharma price target lowered to CHF 150 from CHF 160 at Deutsche Bank
08/13/20 UBS
Vifor Pharma price target lowered to CHF 142 from CHF 149 at UBS
CARA Cara Therapeutics
$13.94 /

-0.07 (-0.50%)

04/22/20 Cantor Fitzgerald
Cara Therapeutics price target raised to $34 from $26 at Cantor Fitzgerald
04/21/20 H.C. Wainwright
Cara Therapeutics price target raised to $33 from $30 at H.C. Wainwright
01/10/20 Stifel
Cara Therapeutics named a BioPharma top pick for 2020 at Stifel
12/19/19 Piper Jaffray
Cara Therapeutics risk/reward 'compelling' at these levels, says Piper Jaffray
CARA Cara Therapeutics
$13.94 /

-0.07 (-0.50%)

CARA Cara Therapeutics
$13.94 /

-0.07 (-0.50%)

Upgrade
Brunswick upgraded to Overweight from Neutral at JPMorgan » 05:18
10/20/20
10/20
05:18
10/20/20
05:18
BC

Brunswick

$62.67 /

-1.29 (-2.02%)

JPMorgan analyst Grace…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BC Brunswick
$62.67 /

-1.29 (-2.02%)

BC Brunswick
$62.67 /

-1.29 (-2.02%)

10/15/20 B. Riley Securities
Brunswick price target raised to $90 from $88 at B. Riley Securities
09/15/20
Fly Intel: Top five analyst initiations
09/15/20 Citi
Brunswick initiated with a Neutral at Citi
07/07/20 KeyBanc
Brunswick price target raised to $72 from $67 at KeyBanc
BC Brunswick
$62.67 /

-1.29 (-2.02%)

BC Brunswick
$62.67 /

-1.29 (-2.02%)

Hot Stocks
SK hynix to acquire Intel NAND memory, storage business for $9B » 05:18
10/20/20
10/20
05:18
10/20/20
05:18
INTC

Intel

$54.60 /

+0.43 (+0.79%)

SK hynix and Intel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INTC Intel
$54.60 /

+0.43 (+0.79%)

INTC Intel
$54.60 /

+0.43 (+0.79%)

10/19/20 Lynx
Intel/SK Hynix deal impact to Western, Micron 'manageable,' says Lynx
10/19/20 Wells Fargo
Western Digital positive reaction to Intel report justifiable, says Wells Fargo
10/19/20 KeyBanc
Potential NAND business sale 'favorable' for Intel and sector, says KeyBanc
10/13/20 Mizuho
AMD price target raised to $90 from $77 at Mizuho
INTC Intel
$54.60 /

+0.43 (+0.79%)

INTC Intel
$54.60 /

+0.43 (+0.79%)

INTC Intel
$54.60 /

+0.43 (+0.79%)

INTC Intel
$54.60 /

+0.43 (+0.79%)

Upgrade
Tiger Brands upgraded to Overweight from Equal Weight at Morgan Stanley » 05:17
10/20/20
10/20
05:17
10/20/20
05:17
TBLMY

Tiger Brands

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TBLMY Tiger Brands
$0.00 /

+ (+0.00%)

02/24/20 HSBC
Tiger Brands downgraded to Reduce from Hold at HSBC
01/30/20 Citi
Tiger Brands downgraded to Sell from Neutral at Citi
Downgrade
WPX Energy downgraded to Sector Weight from Overweight at KeyBanc » 05:16
10/20/20
10/20
05:16
10/20/20
05:16
WPX

WPX Energy

$4.52 /

-0.055 (-1.20%)

KeyBanc analyst Leo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WPX WPX Energy
$4.52 /

-0.055 (-1.20%)

WPX WPX Energy
$4.52 /

-0.055 (-1.20%)

10/16/20
Fly Intel: Top five analyst downgrades
10/16/20 RBC Capital
WPX Energy downgraded to Sector Perform from Outperform at RBC Capital
10/16/20 RBC Capital
WPX Energy downgraded to Sector Perform from Outperform at RBC Capital
09/29/20 TD Securities
WPX Energy downgraded to Tender from Buy at TD Securities
WPX WPX Energy
$4.52 /

-0.055 (-1.20%)

WPX WPX Energy
$4.52 /

-0.055 (-1.20%)

WPX WPX Energy
$4.52 /

-0.055 (-1.20%)

WPX WPX Energy
$4.52 /

-0.055 (-1.20%)

Upgrade
Equatorial Energia upgraded to Hold from Reduce at HSBC » 05:15
10/20/20
10/20
05:15
10/20/20
05:15
EQUEY

Equatorial Energia

$0.00 /

+ (+0.00%)

HSBC analyst Lilyanna…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EQUEY Equatorial Energia
$0.00 /

+ (+0.00%)

06/01/20 Itau BBA
Equatorial Energia downgraded to Market Perform from Outperform at Itau BBA
04/06/20 JPMorgan
Equatorial Energia downgraded to Underweight from Neutral at JPMorgan
11/14/19 Goldman Sachs
Equatorial Energia initiated with a Buy at Goldman Sachs
Downgrade
InterContinental downgraded to Reduce from Add at AlphaValue » 05:14
10/20/20
10/20
05:14
10/20/20
05:14
IHG

InterContinental

$53.23 /

-0.82 (-1.52%)

AlphaValue downgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IHG InterContinental
$53.23 /

-0.82 (-1.52%)

IHG InterContinental
$53.23 /

-0.82 (-1.52%)

10/19/20 Peel Hunt
InterContinental downgraded to Hold from Buy at Peel Hunt
10/15/20 Barclays
InterContinental price target raised to 4,700 GBp from 3,800 GBp at Barclays
10/14/20 Deutsche Bank
InterContinental price target raised to 5,000 GBp at Deutsche Bank
10/08/20 Citi
InterContinental price target raised to 3,100 GBp from 2,250 GBp at Citi
IHG InterContinental
$53.23 /

-0.82 (-1.52%)

Upgrade
EssilorLuxottica upgraded to Outperform from Sector Perform at RBC Capital » 05:13
10/20/20
10/20
05:13
10/20/20
05:13
ESLOY

EssilorLuxottica

$0.00 /

+ (+0.00%)

RBC Capital analyst Piral…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ESLOY EssilorLuxottica
$0.00 /

+ (+0.00%)

10/08/20 Societe Generale
EssilorLuxottica upgraded to Hold from Sell at Societe Generale
10/08/20 Societe Generale
EssilorLuxottica upgraded to Hold from Sell at Societe Generale
10/05/20 Deutsche Bank
Deutsche Bank initiates 'Buy Catalyst Call' on EssilorLuxottica
09/30/20 HSBC
EssilorLuxottica upgraded to Buy at HSBC on expectation for better governance
ESLOY EssilorLuxottica
$0.00 /

+ (+0.00%)

Downgrade
Front Yard downgraded to Market Perform from Outperform at JMP Securities » 05:13
10/20/20
10/20
05:13
10/20/20
05:13
RESI

Front Yard Residential

$13.44 /

+3.5 (+35.21%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RESI Front Yard Residential
$13.44 /

+3.5 (+35.21%)

RESI Front Yard Residential
$13.44 /

+3.5 (+35.21%)

10/19/20 JPMorgan
JPMorgan wouldn't be surprised to see 'some noise' on Front Yard deal price
06/12/20 Northland
Front Yard Residential upgraded to Outperform from Market Perform at Northland
06/08/20 JMP Securities
Front Yard upgraded to Outperform from Market Perform at JMP Securities
05/18/20 Credit Suisse
Front Yard Residential reinstated with an Outperform at Credit Suisse
RESI Front Yard Residential
$13.44 /

+3.5 (+35.21%)

RESI Front Yard Residential
$13.44 /

+3.5 (+35.21%)

Initiation
VIA Optronics initiated with a Buy at Berenberg » 05:12
10/20/20
10/20
05:12
10/20/20
05:12
VIAO

VIA Optronics

$7.92 /

+0.12 (+1.54%)

Berenberg initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 25
    Sep
VIAO VIA Optronics
$7.92 /

+0.12 (+1.54%)

Downgrade
Saab downgraded to Hold from Buy at SEB Equities » 05:11
10/20/20
10/20
05:11
10/20/20
05:11
SAABF

Saab

$0.00 /

+ (+0.00%)

SEB Equities analyst Erik…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAABF Saab
$0.00 /

+ (+0.00%)

06/30/20 Citi
Saab price target lowered to SEK 330 from SEK 390 at Citi
Downgrade
KP Tissue downgraded to Sector Perform from Outperform at RBC Capital » 05:11
10/20/20
10/20
05:11
10/20/20
05:11
KPTSF

KP Tissue

$0.00 /

+ (+0.00%)

RBC Capital analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KPTSF KP Tissue
$0.00 /

+ (+0.00%)

KPTSF KP Tissue
$0.00 /

+ (+0.00%)

07/09/20 Scotiabank
KP Tissue price target raised to C$12.50 from C$12 at Scotiabank
06/15/20 CIBC
KP Tissue price target raised to C$12 from C$11 at CIBC
05/11/20 TD Securities
KP Tissue price target raised to C$11 from C$10 at TD Securities
03/13/20 RBC Capital
KP Tissue price target raised to C$13 from C$12 at RBC Capital
KPTSF KP Tissue
$0.00 /

+ (+0.00%)

Upgrade
Rayonier Advanced upgraded to Outperform from Sector Perform at RBC Capital » 05:10
10/20/20
10/20
05:10
10/20/20
05:10
RYAM

Rayonier Advanced Materials

$4.12 /

+0.04 (+0.98%)

RBC Capital analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RYAM Rayonier Advanced Materials
$4.12 /

+0.04 (+0.98%)

RYAM Rayonier Advanced Materials
$4.12 /

+0.04 (+0.98%)

06/19/20
Fly Intel: Top five analyst upgrades
06/19/20 BofA
Rayonier Advanced Materials double-upgraded to Buy from Underperform at BofA
06/19/20 BofA
Rayonier Advanced Materials upgraded to Buy from Underperform at BofA
06/05/20
Fly Intel: Top five analyst downgrades
RYAM Rayonier Advanced Materials
$4.12 /

+0.04 (+0.98%)

RYAM Rayonier Advanced Materials
$4.12 /

+0.04 (+0.98%)

Upgrade
James Hardie upgraded to Outperform from Sector Perform at RBC Capital » 05:10
10/20/20
10/20
05:10
10/20/20
05:10
JHX

James Hardie

$25.41 /

-0.36 (-1.40%)

RBC Capital analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JHX James Hardie
$25.41 /

-0.36 (-1.40%)

JHX James Hardie
$25.41 /

-0.36 (-1.40%)

08/12/20 Citi
James Hardie downgraded to Neutral from Buy at Citi
06/23/20 Jefferies
James Hardie upgraded to Hold from Underperform at Jefferies
06/08/20 Goldman Sachs
James Hardie resumed with a Buy at Goldman Sachs
05/13/20 Credit Suisse
James Hardie upgraded to Outperform from Neutral at Credit Suisse
JHX James Hardie
$25.41 /

-0.36 (-1.40%)

Earnings
Mercantile Bank reports Q3 EPS 66c, consensus 42c » 05:09
10/20/20
10/20
05:09
10/20/20
05:09
MBWM

Mercantile Bank

$21.32 /

+0.12 (+0.57%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MBWM Mercantile Bank
$21.32 /

+0.12 (+0.57%)

Upgrade
J D Wetherspoon upgraded to Buy from Hold at Stifel » 05:08
10/20/20
10/20
05:08
10/20/20
05:08
JDWPF

J D Wetherspoon

$0.00 /

+ (+0.00%)

Stifel analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JDWPF J D Wetherspoon
$0.00 /

+ (+0.00%)

09/21/20 Morgan Stanley
J D Wetherspoon upgraded to Equal Weight from Underweight at Morgan Stanley
Upgrade
Investor AB upgraded to Buy from Hold at Pareto » 05:06
10/20/20
10/20
05:06
10/20/20
05:06
IVSBF

Investor AB

$0.00 /

+ (+0.00%)

Pareto analyst Herman…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
Signature Bank reports Q3 EPS 2.62, consensus $2.76 » 05:04
10/20/20
10/20
05:04
10/20/20
05:04
SBNY

Signature Bank

$85.93 /

-0.97 (-1.12%)

Reports Q3 book value per…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SBNY Signature Bank
$85.93 /

-0.97 (-1.12%)

10/09/20 Credit Suisse
Signature Bank initiated with an Outperform at Credit Suisse
10/08/20 Piper Sandler
Signature Bank initiated with an Overweight at Piper Sandler
07/22/20 Wells Fargo
Signature Bank price target raised to $125 from $120 at Wells Fargo
05/28/20 Wedbush
Signature Bank upgraded to Outperform at Wedbush
SBNY Signature Bank
$85.93 /

-0.97 (-1.12%)

Initiation
Entra initiated with a Sell at Pareto » 05:03
10/20/20
10/20
05:03
10/20/20
05:03
ENTOF

Entra

$0.00 /

+ (+0.00%)

Pareto initiated coverage…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Upgrade
Scatec Solar upgraded to Buy from Hold at Kepler Cheuvreux » 05:02
10/20/20
10/20
05:02
10/20/20
05:02
STECF

Scatec Solar

$0.00 /

+ (+0.00%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STECF Scatec Solar
$0.00 /

+ (+0.00%)

10/19/20 Pareto
Scatec Solar upgraded to Hold from Sell at Pareto
10/14/20 DNB Markets
Scatec Solar downgraded to Sell from Hold at DNB Markets
Upgrade
Ipsen upgraded to Hold from Reduce at Kepler Cheuvreux » 05:01
10/20/20
10/20
05:01
10/20/20
05:01
IPSEY

Ipsen

$0.00 /

+ (+0.00%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IPSEY Ipsen
$0.00 /

+ (+0.00%)

IPSEY Ipsen
$0.00 /

+ (+0.00%)

09/21/20 Kepler Cheuvreux
Ipsen downgraded to Reduce from Hold at Kepler Cheuvreux
09/01/20 Morgan Stanley
Ipsen price target raised to EUR 101 from EUR 90 at Morgan Stanley
08/26/20 JPMorgan
JPMorgan backs Overweight on Ipsen after palovarotene data
08/04/20 UBS
Ipsen price target raised to EUR 101 from EUR 99 at UBS
Upgrade
Fortinet upgraded to Buy from Neutral at Goldman Sachs » 05:00
10/20/20
10/20
05:00
10/20/20
05:00
FTNT

Fortinet

$128.78 /

-2.81 (-2.14%)

Goldman Sachs analyst…

Goldman Sachs analyst Brian Essex upgraded Fortinet to Buy from Neutral with a price target of $150, up from $143. The stock closed Monday down $2.72 to $128.82. Based on recent conversations with industry participants as well as industry trends this quarter, the analyst believes Fortinet's large enterprise headwinds "may be abating sooner than anticipated." Further, the company's SD-WAN traction still seems to be accelerating and NP7 product cycles remain in early stages, Essex tells investors in a research note. Given its valuation discount to peers, improving execution, product cycle strength and firewall "tailwind," Fortinet is well positioned to outperform from current levels, says the analyst.

ShowHide Related Items >><<
FTNT Fortinet
$128.78 /

-2.81 (-2.14%)

FTNT Fortinet
$128.78 /

-2.81 (-2.14%)

10/15/20 Mizuho
Fortinet price target raised to $130 from $123 at Mizuho
08/26/20 UBS
Fortinet price target raised to $140 from $134 at UBS
08/20/20 Deutsche Bank
Fortinet initiated with a Hold at Deutsche Bank
08/07/20 UBS
Fortinet price target raised to $134 from $122 at UBS
FTNT Fortinet
$128.78 /

-2.81 (-2.14%)

FTNT Fortinet
$128.78 /

-2.81 (-2.14%)

FTNT Fortinet
$128.78 /

-2.81 (-2.14%)

FTNT Fortinet
$128.78 /

-2.81 (-2.14%)

Initiation
PMV Pharmaceuticals initiated with a Neutral at Goldman Sachs » 04:57
10/20/20
10/20
04:57
10/20/20
04:57
PMVP

PMV Pharmaceuticals

$37.84 /

+1.58 (+4.36%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PMVP PMV Pharmaceuticals
$37.84 /

+1.58 (+4.36%)

  • 25
    Sep
PMVP PMV Pharmaceuticals
$37.84 /

+1.58 (+4.36%)

Initiation
Prelude Therapeutics initiated with a Neutral at Goldman Sachs » 04:56
10/20/20
10/20
04:56
10/20/20
04:56
PRLD

Prelude Therapeutics

$32.96 /

+1.36 (+4.30%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRLD Prelude Therapeutics
$32.96 /

+1.36 (+4.30%)

  • 25
    Sep
PRLD Prelude Therapeutics
$32.96 /

+1.36 (+4.30%)

Conference/Events
Roth Capital alternative energy analysts hold analyst/industry conference call » 04:55
10/20/20
10/20
04:55
10/20/20
04:55
ENPH

Enphase Energy

$114.57 /

+3.71 (+3.35%)

, SEDG

SolarEdge

$308.80 /

+6.62 (+2.19%)

, GNRC

Generac

$210.06 /

+1.89 (+0.91%)

, NOVA

Sunnova Energy

$29.95 /

+0.88 (+3.03%)

, RUN

Sunrun

$62.33 /

-0.09 (-0.14%)

, SPWR

SunPower

$17.49 /

+0.51 (+3.00%)

Alternative Energy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENPH Enphase Energy
$114.57 /

+3.71 (+3.35%)

SEDG SolarEdge
$308.80 /

+6.62 (+2.19%)

GNRC Generac
$210.06 /

+1.89 (+0.91%)

NOVA Sunnova Energy
$29.95 /

+0.88 (+3.03%)

RUN Sunrun
$62.33 /

-0.09 (-0.14%)

SPWR SunPower
$17.49 /

+0.51 (+3.00%)

ENPH Enphase Energy
$114.57 /

+3.71 (+3.35%)

10/15/20 Susquehanna
Susquehanna upgrades Enphase Energy on residential growth potential
10/15/20 Susquehanna
Enphase Energy initiated with a Positive at Susquehanna
10/01/20 BofA
Enphase Energy initiated with a Buy at BofA
10/01/20 BofA
Enphase Energy initiated with a Buy at BofA
SEDG SolarEdge
$308.80 /

+6.62 (+2.19%)

10/15/20 Goldman Sachs
SolarEdge upgraded to Neutral from Sell at Goldman Sachs
10/15/20 Susquehanna
SolarEdge initiated with a Positive at Susquehanna
09/30/20 JPMorgan
SolarEdge price target raised to $252 from $222 at JPMorgan
09/23/20 B. Riley FBR
SolarEdge initiated with a Buy at B. Riley FBR
GNRC Generac
$210.06 /

+1.89 (+0.91%)

10/16/20 Stephens
Generac initiated with an Overweight at Stephens
10/15/20 Canaccord
Generac price target raised to $250 from $200 at Canaccord
10/14/20 JMP Securities
Sunnova Energy price target raised to $55 from $43 at JMP Securities
10/07/20 Oppenheimer
Generac price target raised to $225 from $175 at Oppenheimer
NOVA Sunnova Energy
$29.95 /

+0.88 (+3.03%)

10/14/20 JMP Securities
Sunnova Energy price target raised to $55 from $43 at JMP Securities
10/07/20 Piper Sandler
Sunnova Energy initiated with an Overweight at Piper Sandler
09/30/20 JPMorgan
Sunnova Energy assumed with an Overweight at JPMorgan
09/30/20 Roth Capital
Short report on Sunnova Energy 'misses the mark,' says Roth Capital
RUN Sunrun
$62.33 /

-0.09 (-0.14%)

10/07/20 Piper Sandler
Sunrun initiated with a Neutral at Piper Sandler
10/06/20 GLJ Research
SunPower upgraded to Buy from Sell at GLJ Research
09/30/20
Fly Intel: Top five analyst downgrades
09/30/20 JPMorgan
Sunrun price target raised to $79 from $61 at JPMorgan
SPWR SunPower
$17.49 /

+0.51 (+3.00%)

10/07/20
Fly Intel: Top five analyst initiations
10/07/20 Piper Sandler
SunPower initiated with an Overweight at Piper Sandler
10/06/20 GLJ Research
SunPower upgraded to Buy from Sell at GLJ Research
09/30/20 JPMorgan
SunPower price target raised to $13 from $11 at JPMorgan
ENPH Enphase Energy
$114.57 /

+3.71 (+3.35%)

SEDG SolarEdge
$308.80 /

+6.62 (+2.19%)

GNRC Generac
$210.06 /

+1.89 (+0.91%)

NOVA Sunnova Energy
$29.95 /

+0.88 (+3.03%)

RUN Sunrun
$62.33 /

-0.09 (-0.14%)

SPWR SunPower
$17.49 /

+0.51 (+3.00%)

  • 13
    Oct
  • 14
    Aug
  • 01
    Jul
  • 21
    Nov
ENPH Enphase Energy
$114.57 /

+3.71 (+3.35%)

ENPH Enphase Energy
$114.57 /

+3.71 (+3.35%)

SEDG SolarEdge
$308.80 /

+6.62 (+2.19%)

NOVA Sunnova Energy
$29.95 /

+0.88 (+3.03%)

RUN Sunrun
$62.33 /

-0.09 (-0.14%)

SPWR SunPower
$17.49 /

+0.51 (+3.00%)

ENPH Enphase Energy
$114.57 /

+3.71 (+3.35%)

SEDG SolarEdge
$308.80 /

+6.62 (+2.19%)

NOVA Sunnova Energy
$29.95 /

+0.88 (+3.03%)

RUN Sunrun
$62.33 /

-0.09 (-0.14%)

SPWR SunPower
$17.49 /

+0.51 (+3.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.